In relation to Swarup and collaborators paper [12], FUS is demonstrated to be a coactivator of NF-κB, higher in ALS patients than in controls, by direct binding to NF-κB subunit p65 [36]. The gene discussed is NFKB1; the disease is amyotrophic lateral sclerosis.